TC Energy provides results of Series 7 Shares conversion elections
CALGARY, Alberta, April 23, 2024 (GLOBE NEWSWIRE) — – News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy […]
BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2023
TORONTO, April 23, 2024 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that […]
Midland Amends Its Lithium Option Agreement With Rio Tinto With the Addition of the Wookie Project
MONTREAL, April 23, 2024 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD), is pleased to announce the execution of […]
Vishay Intertechnology Board of Directors Issues Statement in Response to Open Letter Submitted by Mountaineer Partners Management
MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today issued the following statement from its […]
AIP Realty Trust Announces Units for Debt Issuance
VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) — AIP Realty Trust (the “Trust” or “AIP”) (TSXV: AIP.U) today announces, […]
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
BOUCHERVILLE, Quebec, April 23, 2024 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV: LSL) (the “Company” or “LSL Pharma”), a […]
Theriva™ Biologics anuncia datos de primera línea positivos del ensayo de fase 1 patrocinado por investigadores de VCN-01 por vía intravítrea en pacientes pediátricos con retinoblastoma refractario
–El Comité de vigilancia del estudio ha determinado que el ensayo de fase 1 en colaboración con el Hospital Infantil […]
GXO Renews Agreement with Mars
PARIS, France, April 23, 2024 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced […]
First Commonwealth Announces First Quarter 2024 Earnings; Increases Quarterly Dividend
INDIANA, Pa., April 23, 2024 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) today announced financial results for the […]
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
TORONTO, April 23, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a […]
